Across TCGA pan-cancer cohorts, MTCO1P17 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MTCO1P17’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where MTCO1P17 RNA is repressed in tumor relative to normal tissue. In most cancer types MTCO1P17 is over-expressed in tumor, although a few such as KIRP and STAD show the opposite, repressed pattern.

KIRP, KICH, and STAD are the cancer types where MTCO1P17 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTCO1P17 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Female	II,III,IV	−0.138	.042	2	view →
KICH	Male	All	+0.064	<.001	2	view →
STAD	Male	IV	−0.075	.004	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MTCO1P17 RNA expression & survival · all MTCO1P17 data types